Clinical Research Directory
Browse clinical research sites, groups, and studies.
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
Sponsor: Essilor International
Summary
The goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essilor® Stellest® at inclusion visit and will be asked for a full time wear (\>12 hours daily) for 24 months. The primary endpoints are the change in axial length and cycloplegic autorefraction from baseline to 24 months compared to expected change based on axial length and refraction centile positions at baseline.
Official title: Post Market Clinical Follow-up Study to Demonstrate the Efficacy, Safety, Acceptability and Quality of Life Implications of Essilor® Stellest® Spectacle Lenses in Slowing Myopia Progression in Children and Adolescents.
Key Details
Gender
All
Age Range
6 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2024-03-22
Completion Date
2027-04-30
Last Updated
2025-12-01
Healthy Volunteers
No
Conditions
Interventions
Essilor® Stellest® spectacle lenses
patients will be asked to wear Essilor® Stellest® spectacle lenses more than 12 hours per day for 24 months.
Locations (3)
Hôpital Fondation Adolphe de Rothschild - Ophthalmology Department
Paris, France
Centre for Eye Research Ireland (CERI) - TU DUBLIN
Dublin, Ireland
Erasmus Medical Center
Rotterdam, Netherlands